Semaglutide
Once-weekly injection, or a daily tablet for adults
A GLP-1 receptor agonist approved as Wegovy for long-term weight management in eligible adults and children 12 and older, alongside reduced-calorie eating and physical activity. Ozempic® is a separate semaglutide product approved for type 2 diabetes.
DailyMed · Wegovy prescribing information (opens in a new tab)



